AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Dose-Response Relationship, RadiationUltraviolet RaysNeoplasmsCarcinogensAneuploidyCell Transformation, NeoplasticIncidenceRadiation DosageRadiation, IonizingRisk AssessmentRadiation InjuriesRisk FactorsRadiation ToleranceRadiationRadiation ProtectionRadiation MonitoringEarly Detection of CancerRadiation OncologyNeoplasms, Radiation-InducedBreast NeoplasmsRadiotherapyRetrospective StudiesCombined Modality TherapyCosmic RadiationFollow-Up StudiesRadiation Injuries, ExperimentalProstatic NeoplasmsRadiation PneumonitisProspective StudiesLung NeoplasmsRadiotherapy DosageStomach NeoplasmsGamma RaysOvarian NeoplasmsColonic NeoplasmsSurvival RateSurvival AnalysisNeoplasm MetastasisRegistriesNeoplasm InvasivenessPrognosisBackground RadiationMice, NudePancreatic NeoplasmsRadiometryCarcinoma, Squamous CellTreatment OutcomeTime FactorsRiskUnited StatesUterine Cervical NeoplasmsGene Expression Regulation, NeoplasticAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRadiation-Sensitizing AgentsNeoplasm StagingCell Line, TumorNeoplasm Recurrence, LocalCancer VaccinesRadiation EffectsCarcinomaNeoplasm ProteinsDisease ProgressionGenetic Predisposition to DiseaseCell SurvivalCarcinoma, Non-Small-Cell LungMutationDisease-Free SurvivalRadiation-Protective AgentsDNA DamageColorectal NeoplasmsHead and Neck NeoplasmsCohort StudiesRadiotherapy, AdjuvantUrinary Bladder NeoplasmsXenograft Model Antitumor AssaysSurvivorsAdenocarcinomaAge DistributionReverse Transcriptase Polymerase Chain ReactionSEER ProgramJapanDrug Resistance, NeoplasmOdds RatioTumor Suppressor Protein p53Chemotherapy, AdjuvantGene Expression ProfilingRectal NeoplasmsTumor Markers, BiologicalNeoplasm TransplantationMultivariate AnalysisSkin NeoplasmsRNA, MessengerNational Cancer Institute (U.S.)Esophageal NeoplasmsRadioactive Hazard ReleaseApoptosisDose FractionationNeoplasms, Second PrimaryCisplatin